These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 18562955

  • 21. Polymorphic repeats in the androgen receptor gene in high-risk sibships.
    Miller EA, Stanford JL, Hsu L, Noonan E, Ostrander EA.
    Prostate; 2001 Aug 01; 48(3):200-5. PubMed ID: 11494335
    [Abstract] [Full Text] [Related]

  • 22. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.
    Bratt O, Borg A, Kristoffersson U, Lundgren R, Zhang QX, Olsson H.
    Br J Cancer; 1999 Oct 01; 81(4):672-6. PubMed ID: 10574254
    [Abstract] [Full Text] [Related]

  • 23. Combination of short CAG and GGN repeats in the androgen receptor gene is associated with acne risk in North East China.
    Pang Y, He CD, Liu Y, Wang KB, Xiao T, Wang YK, Zhu H, Wei B, Zhao N, Jiang Y, Wei HC, Chen HD.
    J Eur Acad Dermatol Venereol; 2008 Dec 01; 22(12):1445-51. PubMed ID: 18624843
    [Abstract] [Full Text] [Related]

  • 24. Association between androgen receptor gene CAG repeat polymorphism and breast cancer risk: a meta-analysis.
    Hao Y, Montiel R, Li B, Huang E, Zeng L, Huang Y.
    Breast Cancer Res Treat; 2010 Dec 01; 124(3):815-20. PubMed ID: 20431938
    [Abstract] [Full Text] [Related]

  • 25. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk.
    Zheng W, Xie D, Cerhan JR, Sellers TA, Wen W, Folsom AR.
    Cancer Epidemiol Biomarkers Prev; 2001 Feb 01; 10(2):89-94. PubMed ID: 11219777
    [Abstract] [Full Text] [Related]

  • 26. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
    Silva Neto B, Koff WJ, Biolchi V, Brenner C, Biolo KD, Spritzer PM, Brum IS.
    Cancer Invest; 2008 Feb 01; 26(1):74-80. PubMed ID: 18181049
    [Abstract] [Full Text] [Related]

  • 27. Population-based case-control study of CYP11A gene polymorphism and breast cancer risk.
    Zheng W, Gao YT, Shu XO, Wen W, Cai Q, Dai Q, Smith JR.
    Cancer Epidemiol Biomarkers Prev; 2004 May 01; 13(5):709-14. PubMed ID: 15159300
    [Abstract] [Full Text] [Related]

  • 28. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
    Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA, Ostrander EA.
    Cancer Res; 1997 Mar 15; 57(6):1194-8. PubMed ID: 9067292
    [Abstract] [Full Text] [Related]

  • 29. Shorter CAG repeat in the AR gene is associated with atypical hyperplasia and breast carcinoma.
    De Abreu FB, Pirolo LJ, Canevari Rde A, Rosa FE, Moraes Neto FA, Caldeira JR, Rainho CA, Rogatto SR.
    Anticancer Res; 2007 Mar 15; 27(2):1199-205. PubMed ID: 17465263
    [Abstract] [Full Text] [Related]

  • 30. The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer.
    Lange EM, Chen H, Brierley K, Livermore H, Wojno KJ, Langefeld CD, Lange K, Cooney KA.
    Cancer Epidemiol Biomarkers Prev; 2000 Apr 15; 9(4):439-42. PubMed ID: 10794490
    [Abstract] [Full Text] [Related]

  • 31. Androgen receptor polymorphisms and the incidence of prostate cancer.
    Chen C, Lamharzi N, Weiss NS, Etzioni R, Dightman DA, Barnett M, DiTommaso D, Goodman G.
    Cancer Epidemiol Biomarkers Prev; 2002 Oct 15; 11(10 Pt 1):1033-40. PubMed ID: 12376504
    [Abstract] [Full Text] [Related]

  • 32. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?
    Mishra D, Thangaraj K, Mandhani A, Kumar A, Mittal R.
    Clin Genet; 2005 Jul 15; 68(1):55-60. PubMed ID: 15952987
    [Abstract] [Full Text] [Related]

  • 33. Polymorphic catechol-O-methyltransferase gene, duration of estrogen exposure, and breast cancer risk: a nested case-control study in Taiwan.
    Lin WY, Chou YC, Wu MH, Jeng YL, Huang HB, You SL, Chu TY, Chen CJ, Sun CA.
    Cancer Detect Prev; 2005 Jul 15; 29(5):427-32. PubMed ID: 16191465
    [Abstract] [Full Text] [Related]

  • 34. Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women.
    Hietala M, Sandberg T, Borg A, Olsson H, Jernström H.
    Hum Reprod; 2007 Jan 15; 22(1):83-91. PubMed ID: 16920725
    [Abstract] [Full Text] [Related]

  • 35. Increased frequency of long androgen receptor CAG repeats in male breast cancers.
    MacLean HE, Brown RW, Beilin J, Warne GL, Zajac JD.
    Breast Cancer Res Treat; 2004 Dec 15; 88(3):239-46. PubMed ID: 15609126
    [Abstract] [Full Text] [Related]

  • 36. The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women.
    Montgomery KG, Chang JH, Gertig DM, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG.
    Breast Cancer Res; 2005 Dec 15; 7(3):R353-6. PubMed ID: 15987430
    [Abstract] [Full Text] [Related]

  • 37. The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese.
    Hirose K, Matsuo K, Toyama T, Iwata H, Hamajima N, Tajima K.
    Cancer Epidemiol Biomarkers Prev; 2004 Aug 15; 13(8):1407-11. PubMed ID: 15298966
    [Abstract] [Full Text] [Related]

  • 38. Association of breast cancer risk with a GT dinucleotide repeat polymorphism upstream of the estrogen receptor-alpha gene.
    Cai Q, Gao YT, Wen W, Shu XO, Jin F, Smith JR, Zheng W.
    Cancer Res; 2003 Sep 15; 63(18):5727-30. PubMed ID: 14522892
    [Abstract] [Full Text] [Related]

  • 39. Steroid hormones polymorphisms and cholelithiasis in Greek population.
    Kitsiou-Tzeli S, Giannatou E, Spanos I, Nicolaidou P, Fretzayas A, Tzetis M, Lazaris D, Kanavakis E, Tsezou A.
    Liver Int; 2007 Feb 15; 27(1):61-8. PubMed ID: 17241382
    [Abstract] [Full Text] [Related]

  • 40. The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series.
    Levine DA, Boyd J.
    Cancer Res; 2001 Feb 01; 61(3):908-11. PubMed ID: 11221880
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.